Site Search
Search Results
Understanding Provider Utilization of Cancer Biomarker Testing
Biomarker testing is an important step to accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. However, not all communities are benefitting from the latest advancements in biomarker testing and precision medicine. ... that prevent patients from benefiting from biomarker testing and precision medicine, and working to ensure all patients benefit, regardless of race, ethnicity, gender, age, sexual orientation, socioeconomic status, or zip code. ACS CAN conducted a survey of 315 oncology providers ...
Understanding Provider Utilization of Cancer Biomarker Testing
Biomarker testing is an important step to accessing precision medicine, including targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. However, not all communities are benefitting from the latest advancements in biomarker testing and precision medicine. ... that prevent patients from benefiting from biomarker testing and precision medicine, and working to ensure all patients benefit, regardless of race, ethnicity, gender, age, sexual orientation, socioeconomic status, or zip code. ACS CAN conducted a survey of 315 oncology providers ...
ACS CAN Comments on DACA proposed rule
Access to care for those who are uninsured not only ensures that serious diseases like cancer can be detected and treated earlier but also often means better patient outcomes and less costs to the individual and the larger health care system. The Affordable Care Act (ACA) expanded health insurance coverage to millions of Americans. However, despite these coverage gains, thirteen years after the law was enacted approximately 31 million people in the United States remain uninsured with data showing that noncitizens are more likely to be uninsured. In 2021, 25% of lawfully present individuals and 46% of undocumented immigrants were uninsured, compared to only 8 percent of U.S. citizens. [1] Deferred Action ...
Early Detection and Screening Can Save Lives & Money
Early detection of breast and cervical cancer through screening can improve survival and reduce mortality by finding cancer at an early stage when treatment is more effective and less expensive. However, ... has shown there are many barriers to cancer screening for people with limited income, including access to providers and facilities, costs of screening and care, lack of knowledge and understanding about the role of screening, as well as barriers like time off work and access to ...
ACS CAN Supports the Access to Breast Cancer Diagnosis Act (S.1500/H.R. 3037)
ACS CAN supports the Access to Breast Cancer Diagnosis Act to increase access to no cost breast cancer screening, including all diagnostic and ... ― including diagnostic and follow-up testing ― are covered without cost-sharing is essential to increasing access and expanding coverage of breast cancer screening. ACS CAN Supports the Access to Breast Cancer Diagnosis Act (S.1500/H.R. 3037) ...
ACS CAN Comments on Section 1557 proposed rule
The American Cancer Society Cancer Action Network (ACS CAN) appreciates the opportunity to comment on the Nondiscrimination in Health Programs and Activities (section 1557) proposed rule. ACS CAN is ... to get screened for cancer and thus are more likely to have their cancer diagnosed at an advanced stage when survival is less likely and the cost of care more expensive. [1] This not only impacts the more than 1.9 million Americans who will be diagnosed with cancer this year, but also the ...
State Tobacco Tax Increases: Explanations and Sources for Projections of New Revenues & Benefits
The economic model developed jointly by the Campaign for Tobacco-Free Kids (TFK), the American Cancer Society Cancer Action Network (ACS CAN), and Economics for Health [1] (housed at the Johns Hopkins Bloomberg School of Public Health) projects the increase in state revenues, public health benefits, and health care cost savings resulting from increases in state cigarette tax rates. The projections are updated annually. Calculations are based on economic ...
ACS CAN Supports the “Increasing Access to Lung Cancer Screening Act” (H.R. 4286)
Background Lung cancer is the leading cause of cancer death for both men and women with 127,070 deaths expected in the U.S. in 2023. An estimated 238,340 new cases of lung cancer will be ... to be treated successfully. Research has shown that access to yearly low-dose CT (LDCT) scans to screen people at higher risk of lung cancer can save lives. Yet despite recommendations for lung cancer screening since 2013 from both the American Cancer Society and the U.S. Preventive ... (D‑NY-26) and Representative Kathy Castor (D-FL-14) the “Increasing Access to Lung Cancer Screening Act:” Provides coverage without cost-sharing for lung cancer screening as recommended by USPSTF to the traditional Medicaid population. Provides coverage for tobacco cessation as ...
Community Letter in Support of the DIVERSE Trials Act (H.R. 5030/S. 2706)
ACS CAN and more than 150 organizations representing patients, providers and health equity advocates sent a letter to Congress urging them to pass the ... allow sponsors to provide patients with technology necessary to facilitate remote participation in clinical trials; and require the Department of Health and Human Services (HHS) to create guidance on the use of decentralized trials to increase trial diversity. Community Letter in Support of the DIVERSE Trials Act (H.R. 5030/S. 2706) ...
Survivor Views: Majority of Cancer Patients & Survivors Have or Expect to Have Medical Debt
Overview: The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views research panel. The panel is a group of cancer patients and survivors who respond to regular surveys and provide important insights to support ACS CAN’s advocacy work at all levels ...
Type
- (-) Remove Resource filter Resource
Priority Issue
Policy Issue
- Access to Health Care (19) Apply Access to Health Care filter
- Prevention and Early Detection (10) Apply Prevention and Early Detection filter
- Research, Funding and Drug Development (7) Apply Research, Funding and Drug Development filter
- Health Equity (4) Apply Health Equity filter
- Patient Quality of Life (3) Apply Patient Quality of Life filter